| Website | mpmcapital.com |
| Phone | 617-425-9200 |
| Employees | |
| Founded | 3/01 |
The MPM BioEquities Fund is a private fund that invests in public, and to a lesser extent, private biotechnology companies. The fund launched in March of 2001 with seed money from CalPERS and other institutions. Managed by Kurt von Emster since its inception, the fund is based in San Francisco and has operations in Boston and New York.
| Company | Date | Round | Size | Participants |
| Metabolex | 4/07 | Series D | $32M | 16 |
| Perlegen Sciences | 2/05 | Series D | $74M | 15 |
